Ranbaxy Laboratories to be Acquired by Sun Pharmaceutical Industries Ltd in Late 2014
CHEMMONITOR.COM – Sun Pharmaceutical Industries Ltd (India) intends to acquire Ranbaxy Laboratories (India) for USD 3.2 billion. The acquisition will create the largest generic drug business in India with profit of USD 4.2 billion. Moreover, the combined business will offer a strong portfolio of generic and specialty materials. The overall value of the purchase, including Ranbaxy Laboratories debt, will total USD 4 billion.